|
[1]Border WA, Noble NA.Mechanism of disease∶transforming growth fac-tor-beta in tissue fibrosis[J].N Engl J Med, 1994, 331∶1286-92.
|
|
[1]Border WA, Noble NA.Mechanism of disease∶transforming growth fac-tor-beta in tissue fibrosis[J].N Engl J Med, 1994, 331∶1286-92.
|
|
[2]Hayasaka A, Saisho H.Serum markers as tools to monitor liver fibrosis[J].Digestion, 1998, 59∶381-384.
|
|
[2]Hayasaka A, Saisho H.Serum markers as tools to monitor liver fibrosis[J].Digestion, 1998, 59∶381-384.
|
|
[3]贾继东, 尹珊珊.肝纤维化的诊断和治疗进展[J].临床内科杂志.2002, 19∶244-246.
|
|
[3]贾继东, 尹珊珊.肝纤维化的诊断和治疗进展[J].临床内科杂志.2002, 19∶244-246.
|
|
[4]蔡卫民, 张彬彬, 翁红雷, 等.八项肝纤维化血清标志物比较研究[J].中华肝脏病杂志, 2004, 12 (4) ∶219-222.
|
|
[4]蔡卫民, 张彬彬, 翁红雷, 等.八项肝纤维化血清标志物比较研究[J].中华肝脏病杂志, 2004, 12 (4) ∶219-222.
|
|
[5]罗瑞红, 杨绍基, 谢俊强, 等.肝纤维化血清五项标志物的诊断意义[J].中华肝脏病杂志, 2001, 9 (3) ∶148-150.
|
|
[5]罗瑞红, 杨绍基, 谢俊强, 等.肝纤维化血清五项标志物的诊断意义[J].中华肝脏病杂志, 2001, 9 (3) ∶148-150.
|
|
[6]陈学福, 陈小萍.血清TGF-β1和HA、LN、CⅣ, PⅢP变化与肝纤维化程度的关系[J].广东医学, 2002, 23∶1042-1043.
|
|
[6]陈学福, 陈小萍.血清TGF-β1和HA、LN、CⅣ, PⅢP变化与肝纤维化程度的关系[J].广东医学, 2002, 23∶1042-1043.
|
|
[7]Oberti F, Valsesia E, Pilette C, et al.Noninvasive diagnosis of hepaticfibrosis or cirrhosis[J].Gastroenterology, 1997, 113∶1609-1616.
|
|
[7]Oberti F, Valsesia E, Pilette C, et al.Noninvasive diagnosis of hepaticfibrosis or cirrhosis[J].Gastroenterology, 1997, 113∶1609-1616.
|
PDF下载 ( 81 KB)
本文二维码
下载:
